Tag: SOF-VAC
ASX biotech firm Noxopharm’s new mRNA enhancer to make vaccines safer
Australian biotech company Noxopharm Limited unveiled today the development of a new mRNA vaccine enhancer that will make mRNA vaccines safer by reducing inflammation associated with mRNA vaccines.
Featured Article
Future-ready manufacturing: How AI and cloud ERP are transforming supply chains
As manufacturers face growing supply chain disruption, rising costs and increasing operational complexity, artificial intelligence (AI), cloud ERP and connected digital systems are becoming essential tools for improving visibility, resilience and decision-making.
